Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin

Diabetes mellitus (DM) is associated with increased platelet activation and reduced platelet inhibition by clopidogrel. Prostaglandin E1 (PGE1) stimulates adenyl cyclase activity in platelets and increases cyclic AMP concentrations, which inhibit Ca(2+)release and platelet aggregation induced by P2Y...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: KREUTZ, ROLF P., NYSTROM, PERRY, KREUTZ, YVONNE, MIAO, JIA, KOVACS, RICHARD, DESTA, ZERUESENAY, FLOCKHART, DAVID A., JIN, YAN
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4028123/
https://ncbi.nlm.nih.gov/pubmed/22385219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/09537104.2012.661107
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller